Logo image of NRXP

NRX PHARMACEUTICALS INC (NRXP) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:NRXP - US6294442099 - Common Stock

2.44 USD
+0.05 (+2.09%)
Last: 12/24/2025, 7:51:20 PM
2.47 USD
+0.03 (+1.23%)
After Hours: 12/24/2025, 7:51:20 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
NRXP revenue by date.NRXP revenue by date.
N/AN/A
643.59%
N/A
284.23%
N/A
104.42%
N/A
69.69%
N/A
8.59%
N/A
33.14%
N/A
0.37%
EBITDA
YoY % growth
NRXP ebitda by date.NRXP ebitda by date.
N/AN/AN/AN/A-94.428M-44.331M
53.05%
-27.582M
37.78%
-19.699M
28.58%
N/A
29.06%
N/A
165.69%
N/A
713.33%
N/A
171.44%
N/A
47.71%
N/A
33.42%
N/AN/A
EBIT
YoY % growth
NRXP ebit by date.NRXP ebit by date.
-134.5K-1.007M
-648.33%
-713.2K
29.14%
-907.4K
-27.23%
-94.43M
-10,306.66%
-44.335M
53.05%
-27.587M
37.78%
-19.704M
28.58%
N/A
43.85%
N/A
736.15%
N/A
291.25%
N/A
120.13%
N/A
98.13%
N/A
5.25%
N/A
89.32%
N/A
1.71%
Operating Margin
NRXP operating margin by date.NRXP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NRXP eps by date.NRXP eps by date.
N/AN/AN/AN/AN/AN/A-4.00
39.04%
-2.31
42.25%
N/A
66.00%
N/A
278.57%
N/A
140.73%
N/A
51.06%
N/A
9.80%
N/A
7.10%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.02
103.09%
-0.07
68.43%
0.01
101.65%
0.07
113.26%
0.23
857.27%
Revenue
Q2Q % growth
9.282M22.95M28.05M33.762M
13,851.24%
36.655M
294.90%
EBITDA
Q2Q % growth
-2.142M
40.98%
10.914M
391.27%
11.016M
395.34%
10.608M
750.00%
N/A
EBIT
Q2Q % growth
769.417K
121.17%
10.404M
377.66%
10.506M
381.66%
10.098M
1,763.87%
16.964M
2,104.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.50
-284.62%
-0.09-0.41-476.70%
Q2 2025
Q2Q % growth
-0.31
53.73%
-0.21-0.10-49.47%
Q1 2025
Q2Q % growth
-0.21
71.62%
-0.310.1031.37%
Q4 2024
Q2Q % growth
-0.77
-54.00%
-0.32-0.45-138.39%
Q3 2024
Q2Q % growth
-0.13
81.43%
-0.650.5280.09%
Q2 2024
Q2Q % growth
-0.67
44.17%
-0.710.045.49%
Q1 2024
Q2Q % growth
-0.74
53.75%
-0.56-0.18-31.91%
Q4 2023
Q2Q % growth
-0.50
68.75%
-0.710.2129.97%
Q3 2023
Q2Q % growth
-0.70
50.00%
-1.160.4639.44%
Q2 2023
Q2Q % growth
-1.20
-9.09%
-1.390.1913.92%
Q1 2023
Q2Q % growth
-1.60
-661.90%
-1.43-0.17-12.04%
Q4 2022
Q2Q % growth
-1.60
-1,677.78%
-1.48-0.12-8.18%
Q3 2022
Q2Q % growth
-1.40
-250.00%
-1.430.031.96%
Q2 2022
Q2Q % growth
-1.10
-189.47%
-1.02-0.08-7.84%
NRXP Yearly EPS VS EstimatesNRXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 -6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
242K 6.962M-6.72M-96.52%
Q2 2025
Q2Q % growth
1.53M-1.53M-100.00%
Q1 2025
Q2Q % growth
1.16M-1.16M-100.00%
NRXP Yearly Revenue VS EstimatesNRXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS1.93% 1.93% -175% -327.78%
Revenue0% 0% -28.41% -28.41%